Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Fresenius Kabi has commenced voluntary recall of two batches of 1 mg dosage breast cancer drug anastrozole tablets shipped to the US, as the firm found other medicines in some of the bottles.
Subscribe to our email newsletter
The German drugmaker is recalling 7,192 bottles, each bottle containing 30 1-mg tablets, which expire in May 2011, the Economic Times reported.
The German drugmaker informed the US Food and Drug Administration about the recall on 1 September.
Anastrozole tablets made at Fresensius Kabi Oncology’s plant in Baddi (Himachal Pradesh, India) was launched just three months ago. The tablets are sold in the US through Fresenius Kabi’s local unit APP Pharmaceuticals.
Fresenius Kabi had acquired Fresenius Kabi Oncology, formerly known as Dabur Pharma, from Burmans of Dabur Group in 2008.